PATENT CLAIM ANALYSIS

Application Number: 15882504
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "400000"]

Abstract:
Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a T max  as quick as 2 minutes and not later than 30 minutes in the majority of subjects.

Claim (Index 8):
The system of  claim 1  wherein the solid formulation coating comprises zolmitriptan or salt thereof and an acid selected from the group consisting of malic acid, ascorbic acid, lactic acid, tartaric acid, citric acid, maleic acid, succinic acid and hydrochloric acid, and wherein the zolmitriptan or salt thereof and the acid are present in a ratio w/w from about 2:1 to about 4:1 and wherein the composition is substantially free of a penetration enhancer.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.38889
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14497595', '12853922', '12608445', '13105562', '14280117']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7764748540090297
- 35 USC 102 Novelty (BERT): 0.5153028646681369
- Combined Prediction Score: 0.7503576550749405
- Mean Citation Score: 259.036516
- Max Citation Score: 269.51328
- Similarity Product: 155.63159406995774

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test